David Ortega-Alarcon

6PUBLICATIONS
27CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsProteins and peptidesGlycoconjugatesCell physiologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 19, 2024
Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 Mpro Main Protease Inhibitor through Intensive Virtual Screening and In Vitro Evaluation.

Maria Nuria Peralta-Moreno, Yago Mena, David Ortega-Alarcon

|Apr 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors.

Maria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon

|Oct 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cells.

Luca Sancineto, Carmine Ostacolo, David Ortega-Alarcon

|Oct 13, 2021
Residual Helicity at the Active Site of the Histidine Phosphocarrier, HPr, Modulates Binding Affinity to Its Natural Partners.

José L Neira, David Ortega-Alarcón, Bruno Rizzuti

|Sep 28, 2021
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds.

Bruno Rizzuti, Laura Ceballos-Laita, David Ortega-Alarcon

|Aug 27, 2021
Stabilization Effect of Intrinsically Disordered Regions on Multidomain Proteins: The Case of the Methyl-CpG Protein 2, MeCP2.

David Ortega-Alarcon, Rafael Claveria-Gimeno, Sonia Vega

Pageof 1

Frequent Collaborators

6 joint publications

Adrian Velazquez-Campoy

5 joint publications

Olga Abian

2 joint publications

Bruno Rizzuti

2 joint publications

Laura Ceballos-Laita